Atreca, Inc BCEL

thephysicsguy1

If you look at this chart, definitely looks like BCEL is ripe for a pop. The blue line I have on there would be where I'd start thinking about selling, probably 5 cents less than that and it's going down hill.

PennyStock101 Premium

Atreca, Inc., a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in...

thephysicsguy1

I'm looking at Biotechnologies and healthcare sector for my next sector that is going to run beyond the oil industry. Oil is going to die down in the next week or two because the Biden admin will want that to go hush hush. I estimate we will still have one or two more really rallies in the oil industry before we see the whole sector of biotech go nuts. Again...

WORTH1MILby2025

Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later.

Swing_Trading_as_a_BUSINESS

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using...

Swing_Trading_as_a_BUSINESS

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using...

Kroxboy Pro

Hull Moving Averages ( x3) all turned up going to run up for awhile with some dips. in at $13.08 x 400

gatto_nero

price drop after public offering at $16 in future stock should test $24

dogchasingcogChasingCars Premium

Atreca has come down to rising channel support. There's also the 100 ema involved, which has many times acted as watershed support\resistance (YELLOW arrows). If this channel and moving average hold, BCEL could quickly go back to all-time highs for a 44% gain. If channel breaks to the downside, March lows are 40% away. I would absolutely wait for solid...

arkeyrml Pro

Please leave a like and follow for more

abipandaswim

This is a review of my previous chart setup. Over 18%! I’m rich now lol. My best chart setup so far. Glad some of you guys could have made money on this one. If you want to hold this stock that’s completely ok but I am going to sell tomorrow.

abipandaswim

Closed over support with super high volume! Is the bearish trend over?